Danaher Corp
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
What If You Bought DHR Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Oct 2, 2023 | $219.95 | 141-for-125 | 1.128× | 47.610623999999994× |
| Jul 5, 2016 | $68.77 | 1319-for-1000 | 1.319× | 42.208× |
| Jun 14, 2010 | $26.44 | 2-for-1 | 2× | 32× |
| May 21, 2004 | — | 2-for-1 | 2× | 16× |
| Jun 1, 1998 | — | 2-for-1 | 2× | 8× |
| Jan 23, 1995 | — | 2-for-1 | 2× | 4× |
| Sep 9, 1987 | — | 2-for-1 | 2× | 2× |
Danaher Corp Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 7 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.